Metabolon, a US-based diagnostics and services company for the biochemical industry backed by crop company Syngenta’s corporate venturing unit, is reportedly preparing to raise $10m this year and more next year.
News provider News Observer said Metabolon had raised $32m since 2000 and would raise $10m later this year. Metabolon extended its series C round to $12.3m October 2009 with Syngenta Ventures and venture capital firms Fletcher Spaght Ventures, Sevin Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities investing.
Carol Marino, vice-president of Syngenta Ventures, joined Metabolon’s board at that time.